Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston,...
Surgery may improve survival for patients who receive targeted therapies for metastatic renal cell cancer, according to a study by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (Boston,...
...